2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH
——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-β Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation SHANGHAI, May 17, 2025 /PRNewswire/ -- At the European Association for the Study of the Liver (EASL) Annual...
SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment
TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at the prestigious 2025 American Thoracic Society (ATS)...
Acer Gadget Unveils New AI-Powered Wearables at COMPUTEX 2025
Debuts the company's first AI translation earbuds and smart ring for AI-enhanced communication and wellness tracking; Also showcases the latest e-mobility products Editor's Summary: Acer Gadget introduces the Acer FreeSense Ring, a lightweight...
Fabric8Labs' ECAM Technology Selected by AEWIN for Advanced Thermal Management Solutions
SAN DIEGO, May 14, 2025 /PRNewswire/ -- Fabric8Labs, Inc., the pioneer of Electrochemical Additive Manufacturing (ECAM), today announced its novel manufacturing technology has been selected by AEWIN Technologies, a leading provider of...
LG Display Targets Future Markets with World-Leading Technology at SID Display Week 2025
SEOUL, South Korea, May 14, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, is demonstrating its OLED technology leadership at the world's largest display exhibition. Under the theme, "Display Technologies...
CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy
SHANGHAI, May 12, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces preliminary clinical data for CT0596, an allogeneic BCMA-targeted CAR-T...
ISX Financial Reports Strong Q1 2025 Results, Demonstrating Strategic Momentum and Innovation in BankTech
NICOSIA, Cyprus, May 6, 2025 /PRNewswire/ -- ISX Financial EU Plc ('ISXPlc'), a leading European BankTech and payments infrastructure provider, today announced its Q1 2025 results, delivering sustained growth across key financial and operational...
Vietnam: A Hub for Accessible World-Class British Transnational Education for Resilient Global Graduates
HANOI, Vietnam, April 28, 2025 /PRNewswire/ -- Vietnam is emerging as a leading destination for affordable British transnational education (TNE) in Southeast Asia, offering high-quality local programmes that develop resilient global graduates....
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
HONG KONG, April 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical Products...
Four AT128 Lidar Sensors from Hesai Selected as Primary Lidar for All Pony.ai Seventh-Generation Robotaxis
SHANGHAI, April 24, 2025 /PRNewswire/ -- Hesai Group (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotic applications, today announced that its long-range, automotive-grade AT128 lidar has been selected as the...